Lasa Supergenerics Ltd

NSE: LASA · BSE: 540702 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹4.22
Market cap: ₹21.14 Cr
Revenue (annual): ₹25.14 Cr
Net profit (annual): ₹-34.09 Cr
P/E (TTM): -1.3×Sector 43.8×
Promoter holding: 53.65%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 5 Other Announcement 4 Board Meeting Date 3 Annual General Meeting 2 Management Change 1 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Sep 2026 17:01 IST BSE

Annual General Meeting

Lasa Supergenerics Annual General Meeting

Lasa Supergenerics Limited held its 11th Annual General Meeting on September 30, 2026. Seven business items, including appointment of a director and borrowing powers, were discussed.

Open announcement → Read the filing ↗

9 Sep 2026 17:30 IST BSE

Annual General Meeting

Lasa Supergenerics Annual General Meeting

Lasa Supergenerics Limited has issued a notice for its Annual General Meeting to be held on September 30, 2026, featuring seven agenda items.

Open announcement → Read the filing ↗